India's Wockhardt hits near 2-yr high after completion of pneumonia study

Wockhardt

11/12/2023 07:39

** Shares of pharma and biotechnology co Wockhardt  WCKH.NS 
rose as much as 18.8% to 399 rupees, hitting highest since Jan.
17, 2022
    ** Co announces completion of Phase 3 pneumonia study of its
macrolide antibiotic, used to treat bacterial infections
    ** Stock up after four straight sessions of losses
    ** Stock on track for yearly gains after two straight years
of losses
    ** More than 359.2 mln shares traded this year - most active
year since 2018 
    ** Stock last up 16%, adding to YTD gains of ~75%

 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))